Released Title Price Sensitive Download Types
2022-01-05 08:23:24 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/00db2be1f6f660db2ecc601b287a16d5
    Substantial Holdings
2022-01-25 08:18:50 Immutep Quarterly Activities Report and Appendix 4C 1 https://app.sharelinktechnologies.com/announcement/asx/0e0e67ff095c3efa3253c9d9a7844854
    Quarterly Reports
2022-01-31 10:40:16 Immutep to present at February Investor Conferences 0 https://app.sharelinktechnologies.com/announcement/asx/7c4c61f38bcad22f5c4e81e4f215a6ef
    Company Administration General
2022-02-02 08:18:36 Death of Director Grant Chamberlain 0 https://app.sharelinktechnologies.com/announcement/asx/1e3bbbba1e0163e36e79308c8e49e8c1
    Company Administration General
    Appointment / Resignation
2022-02-02 08:25:01 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/57f602c1e0bdaac0c5df24cd3b805f0c
    Substantial Holdings
2022-02-11 11:58:36 Australian Patent Granted for Efti with PD-1 Inhibitors 1 https://app.sharelinktechnologies.com/announcement/asx/91d480e4b27e7ebf24d206d73915f203
    Progress Report
2022-02-18 08:11:43 Immutep Investor Update 0 https://app.sharelinktechnologies.com/announcement/asx/dd8a714580b1f014a5cabb1b6d5e2663
    Periodic Report General
    Progress Report
2022-02-18 08:13:33 Immutep to present new data from TACTI-002 at ELCC 2022 0 https://app.sharelinktechnologies.com/announcement/asx/2e27f374def606db20ab9ff1bf1acffc
    Company Administration General
    Progress Report
2022-02-23 18:22:45 Half Yearly Report and Accounts 1 https://app.sharelinktechnologies.com/announcement/asx/3d62248a762c28f3983af96607a4e8e8
    Periodic Report General
    Half Year Reports
2022-02-24 08:01:34 Immutep to Present at Healthcare Investor Conferences 0 https://app.sharelinktechnologies.com/announcement/asx/cc098abfbb1d4abe9143daeaa2a57845
    Company Report General
    Company Administration General
2022-02-25 08:01:06 Appointment of Non-Executive Director 0 https://app.sharelinktechnologies.com/announcement/asx/5114c43f4ca9391093563ff9ee816ff9
    Appointment / Resignation
2022-02-25 15:42:58 Proposed issue of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/f202ddb129ad33ecd5170a021c5a534a
    Issued Capital General
2022-02-25 15:51:58 Initial Directors Interest Notice - Lucy Turnbull 0 https://app.sharelinktechnologies.com/announcement/asx/b15aaa0655ad351aa12fa99194a3b413
    Director's Interest
2022-03-10 08:25:00 Immutep receives FDA feedback for Efti development in MBC 1 https://app.sharelinktechnologies.com/announcement/asx/98cf683268722c4727291ef0b3fe40b0
    Progress Report
2022-03-11 09:26:28 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/bd72c48dc0035ab3d96125099347e1c5
    Issued Capital General
2022-03-16 08:23:12 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/312f2a56f77757541572b4b0bff8723c
    Substantial Holdings
2022-03-18 15:36:03 Japanese patent granted for LAG-3 antibody LAG525 1 https://app.sharelinktechnologies.com/announcement/asx/2b750ab5f1911309b27b06387b6e5ed0
    Progress Report
2022-03-18 16:18:28 Immutep to present Phase IIb breast cancer data at ESMO 2022 0 https://app.sharelinktechnologies.com/announcement/asx/c6673b1400a16b411c92588aa3c82f3e
    Company Administration General
    Progress Report
2022-03-24 08:19:42 Immutep announces publication of ELCC 2022 abstract 1 https://app.sharelinktechnologies.com/announcement/asx/e43a8c00f18c5c9a99ff00b63c90fcfb
    Progress Report
2022-03-30 08:24:59 Efti with Keytruda shows encouraging activity in lung cancer 1 https://app.sharelinktechnologies.com/announcement/asx/448a1148ce248641ef6fbfcffd65c23f
    Progress Report
2022-04-08 08:20:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/cbc9c329deca5d4e076f2c4cdd182337
    Substantial Holdings
2022-04-28 08:22:26 Immutep to announce new TACTI-002 data at ASCO 2022 1 https://app.sharelinktechnologies.com/announcement/asx/e5f86522cb9f53c660d67188d91557d3
    Progress Report
2022-04-29 08:01:08 Quarterly Activities/Appendix 4C Cash Flow Report 1 https://app.sharelinktechnologies.com/announcement/asx/60bfd95c5563c8f9a6cbb27c800ee00c
    Quarterly Reports
2022-05-04 18:54:54 New & significant data from AIPAC phase 2b trial in MBC 1 https://app.sharelinktechnologies.com/announcement/asx/2e2b67c26854717d0a6d553e8b51bddf
    Progress Report
2022-05-18 08:17:18 Leading Oncologists appointed to Clinical Advisory Board 0 https://app.sharelinktechnologies.com/announcement/asx/70b6097d27579f8e3c6b278e96843e54
    Company Administration General
2022-05-20 08:22:21 Immutep to Present at Investor Conferences 0 https://app.sharelinktechnologies.com/announcement/asx/8029cd741f6aa0cad4a6568c1949384e
    Company Report General
    Company Administration General
2022-05-24 17:28:34 Immutep Corporate Presentation 0 https://app.sharelinktechnologies.com/announcement/asx/fe7f8931e148b22044c7bd936452d128
    Periodic Report General
2022-05-27 07:34:10 Immutep announces publication of ASCO 2022 abstracts 1 https://app.sharelinktechnologies.com/announcement/asx/815497295cd7579ee8bd97814846d9f3
    Progress Report
2022-06-02 08:17:31 Immutep webcast for TACTI-002 data presented at ASCO 2022 0 https://app.sharelinktechnologies.com/announcement/asx/21143bb3b8da117415aa878e361611df
    Company Report General
    Company Administration General
2022-06-06 08:20:54 Positive ORR in 1st line NSCLC from ph 2 TACTI-002 trial 1 https://app.sharelinktechnologies.com/announcement/asx/c895b7682eeb363c6eb6bf5e68c9dd3b
    Progress Report
2022-06-06 09:04:40 Webcast slides for 1st line NSCLC data from TACTI-002 trial 1 https://app.sharelinktechnologies.com/announcement/asx/924b471b4ed88105ad6bab3e98eb0ee4
    Periodic Report General
    Progress Report
2022-06-17 12:38:17 Immutep Investor Update 0 https://app.sharelinktechnologies.com/announcement/asx/218f89c560069f29ccbc9767ef846df8
    Progress Report
2022-06-27 09:29:45 TACTI-002 lung cancer data to be presented at 2022 WCLC 0 https://app.sharelinktechnologies.com/announcement/asx/c6791eb4ce762fa3de673bda6b7aab3f
    Company Administration General
Powered by Share Link